Published in Biogerontology on October 10, 2009
Associations between ionomic profile and metabolic abnormalities in human population. PLoS One (2012) 0.95
High serum Cu and Cu/Zn ratios correlate with impairments in bone density, physical performance and overall health in a population of elderly men with frailty characteristics. Exp Gerontol (2012) 0.80
Zinc: dietary intake and impact of supplementation on immune function in elderly. Age (Dordr) (2012) 0.80
Cu to Zn ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study). Age (Dordr) (2011) 0.79
Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation. Genes Nutr (2014) 0.78
Zinc in Infection and Inflammation. Nutrients (2017) 0.77
Evaluation of local trace element status and 8-Iso-prostaglandin F2α concentrations in patients with Tinea pedis. Biol Proced Online (2016) 0.76
Nutritional and Metabolic Biomarkers in Autism Spectrum Disorders: An Exploratory Study. Integr Med (Encinitas) (2015) 0.75
Effects of zinc-fortified drinking skim milk (as functional food) on cytokine release and thymic hormone activity in very old persons: a pilot study. Age (Dordr) (2014) 0.75
Serum Zn/Cu Ratio Is Associated with Renal Function, Glycemic Control, and Metabolic Parameters in Japanese Patients with and without Type 2 Diabetes: A Cross-sectional Study. Front Endocrinol (Lausanne) (2016) 0.75
Copper Deficiency in the Lungs of TNF-α Transgenic Mice. Front Physiol (2016) 0.75
Nutritional Risk, Micronutrient Status and Clinical Outcomes: A Prospective Observational Study in an Infectious Disease Clinic. Nutrients (2016) 0.75
Copper to Zinc Ratio as Disease Biomarker in Neonates with Early-Onset Congenital Infections. Nutrients (2017) 0.75
Main biomarkers associated with age-related plasma zinc decrease and copper/zinc ratio in healthy elderly from ZincAge study. Eur J Nutr (2016) 0.75
BRAF mutation predicts sensitivity to MEK inhibition. Nature (2005) 17.14
Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors. Oncogene (2003) 3.32
Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol (2012) 3.20
Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. JAMA Intern Med (2013) 3.08
Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling. Clin Cancer Res (2003) 2.33
T cells and aging, January 2002 update. Front Biosci (2002) 2.14
Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project. Drugs Aging (2014) 2.03
Rotating-shift nurses after a day off: peripheral clock gene expression, urinary melatonin, and serum 17-β-estradiol levels. Scand J Work Environ Health (2014) 1.50
Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90. Chem Biol (2004) 1.38
The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells. Cancer Res (2003) 1.35
Dysregulation of T-cell function in the elderly : scientific basis and clinical implications. Drugs Aging (2005) 1.23
Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med (2011) 1.23
Comorbidity and social factors predicted hospitalization in frail elderly patients. J Clin Epidemiol (2004) 1.20
Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology (2006) 1.20
Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech Ageing Dev (2012) 1.19
Moving against frailty: does physical activity matter? Biogerontology (2010) 1.19
Prevalence and risk factors for falls in an older community-dwelling population. J Gerontol A Biol Sci Med Sci (2002) 1.13
Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging (2010) 1.11
Development of purine-scaffold small molecule inhibitors of Hsp90. Curr Cancer Drug Targets (2003) 1.11
Physical activity and mortality in frail, community-living elderly patients. J Gerontol A Biol Sci Med Sci (2004) 1.09
Metalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implications. Curr Opin Pulm Med (2011) 1.08
Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerontology (2006) 1.07
Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients. Clin Biochem (2012) 1.06
The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. Drug Saf (2012) 1.05
Global DNA methylation in old subjects is correlated with frailty. Age (Dordr) (2011) 1.05
Adverse drug events as a cause of hospitalization in older adults. Drug Saf (2012) 1.05
Relationship of job satisfaction, psychological distress and stress-related biological parameters among healthy nurses: a longitudinal study. J Occup Health (2009) 1.02
Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of +647 MT1a and -174 IL-6 polymorphic alleles. Exp Gerontol (2007) 1.02
Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging (2012) 1.02
Zinc dyshomeostasis: a key modulator of neuronal injury. J Alzheimers Dis (2005) 1.00
Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev (2008) 1.00
NK and NKT cells in aging and longevity: role of zinc and metallothioneins. J Clin Immunol (2009) 1.00
RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosis. Cancer Biol Ther (2005) 1.00
Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment. Diabetes Care (2010) 0.98
Polypharmacy and health outcomes among older adults discharged from hospital: results from the CRIME study. Geriatr Gerontol Int (2014) 0.98
Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes. Trends Mol Med (2008) 0.98
Rotating shift-work as an independent risk factor for overweight Italian workers: a cross-sectional study. PLoS One (2013) 0.97
Potentially inappropriate medication in elderly hospitalized patients. Drugs Aging (2009) 0.97
Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects. J Nutr Biochem (2009) 0.97
Indwelling urethral catheter and mortality in frail elderly women living in community. Neurourol Urodyn (2004) 0.97
Immunosupportive therapies in aging. Clin Interv Aging (2007) 0.97
Regimen complexity and medication nonadherence in elderly patients. Ther Clin Risk Manag (2009) 0.96
Potentially inappropriate medications and functional decline in elderly hospitalized patients. J Am Geriatr Soc (2009) 0.95
Identification of lead compounds as antagonists of protein Bcl-xL with a diversity-oriented multidisciplinary approach. J Med Chem (2009) 0.95
Predictors of hospitalization in Italian nursing home residents: the U.L.I.S.S.E. project. J Am Med Dir Assoc (2011) 0.95
Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Exp Gerontol (2006) 0.94
Zinc and inflammatory/immune response in aging. Ann N Y Acad Sci (2007) 0.94
Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc. J Nutr Biochem (2012) 0.94
Zinc homeostasis in aging: two elusive faces of the same "metal". Rejuvenation Res (2006) 0.93
Prognostic significance of the short physical performance battery in older patients discharged from acute care hospitals. Rejuvenation Res (2011) 0.93
The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol (2004) 0.92
Prognostic stratification of elderly patients in the emergency department: a comparison between the "Identification of Seniors at Risk" and the "Silver Code". J Gerontol A Biol Sci Med Sci (2011) 0.92
Heat shock response by EBV-immortalized B-lymphocytes from centenarians and control subjects: a model to study the relevance of stress response in longevity. Exp Gerontol (2004) 0.92
Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur J Hum Genet (2002) 0.91
Potentially reversible risk factors and urinary incontinence in frail older people living in community. Age Ageing (2003) 0.91
Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology (2005) 0.91
Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients. Biogerontology (2006) 0.91
Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study. Biogerontology (2006) 0.91
Integrative genomics revealed RAI3 is a cell growth-promoting gene and a novel P53 transcriptional target. J Biol Chem (2005) 0.90
Correlation between zinc status and immune function in the elderly. Biogerontology (2006) 0.90
1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients. Mech Ageing Dev (2005) 0.90
Pro-inflammatory genetic background and zinc status in old atherosclerotic subjects. Ageing Res Rev (2008) 0.90
Mediterranean diet and plasma concentration of inflammatory markers in old and very old subjects in the ZINCAGE population study. Clin Chem Lab Med (2008) 0.90
Effect of zinc on cellular poly(ADP-ribosyl)ation capacity. Exp Gerontol (2007) 0.89
Targeting inflammation to slow or delay functional decline: where are we? Biogerontology (2010) 0.89
Single and three-color flow cytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: relationship with metallothioneins. Cytometry A (2006) 0.89
Characterization of the hsp70 response in lymphoblasts from aged and centenarian subjects and differential effects of in vitro zinc supplementation. Exp Gerontol (2004) 0.89
A novel, population-specific approach to define frailty. Age (Dordr) (2010) 0.89
Infection, immunity and the neuroendocrine response. Vet Immunol Immunopathol (2009) 0.88
Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis (2005) 0.88
Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev (2003) 0.88
Influence of shift-work on selected immune variables in nurses. Ind Health (2011) 0.88
Zinc deficiency and IL-6 -174G/C polymorphism in old people from different European countries: effect of zinc supplementation. ZINCAGE study. Exp Gerontol (2008) 0.88